Acquisition of Reagents for HLA Allosensitization Definition in Clinical Histocompatibility, for the HLA Serology Laboratories (Transplantation Area) of IPST, IP.

This tender, processed via Direct Award CM Contract No. 4101426, focuses on the procurement of essential reagents for defining Human Leukocyte Antigen (HLA) allosensitization. These reagents are critical for clinical histocompatibility testing, a process vital in organ and tissue transplantation. HLA typing and the detection of anti-HLA antibodies (allosensitization) are crucial for matching donors and recipients, thereby minimizing the risk of graft rejection and improving transplant success rates. The reagents will be supplied to the HLA Serology Laboratories, specifically within the Transplantation Area, of the Instituto Português de Sangue e Transplantação, I.P. (IPST, IP). The IPST is the national blood and transplantation institute, underscoring the importance of this procurement for the Portuguese healthcare system. The direct award procedure suggests a specific, possibly urgent, need or a pre-existing framework agreement. The acquisition ensures that these specialized laboratories have the necessary materials to perform accurate and timely immunological assessments for transplant candidates and recipients.

This is a supplies contract in the general supplies sector. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 40,092.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.